The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Esomeprazole Market Research Report 2024
Synopsis
Esomeprazole drug market in this report.
The global Esomeprazole market was valued at US$ 134 million in 2023 and is anticipated to reach US$ 212.2 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
North American market for Esomeprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Esomeprazole include AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi and Mepha, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Esomeprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Esomeprazole.
Report Scope
The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Esomeprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Segment by Type
Capsule
Tablet
Others
Segment by Application
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Esomeprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Esomeprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Esomeprazole drug market in this report.
The global Esomeprazole market was valued at US$ 134 million in 2023 and is anticipated to reach US$ 212.2 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
North American market for Esomeprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Esomeprazole include AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi and Mepha, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Esomeprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Esomeprazole.
Report Scope
The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Esomeprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Segment by Type
Capsule
Tablet
Others
Segment by Application
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Esomeprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Esomeprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Esomeprazole Market Overview
1.1 Product Overview and Scope of Esomeprazole
1.2 Esomeprazole Segment by Type
1.2.1 Global Esomeprazole Market Value Comparison by Type (2024-2030)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Others
1.3 Esomeprazole Segment by Application
1.3.1 Global Esomeprazole Market Value by Application: (2024-2030)
1.3.2 Gastroesophageal Reflux Disease
1.3.3 Duodenal Ulcers
1.3.4 Others
1.4 Global Esomeprazole Market Size Estimates and Forecasts
1.4.1 Global Esomeprazole Revenue 2019-2030
1.4.2 Global Esomeprazole Sales 2019-2030
1.4.3 Global Esomeprazole Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Esomeprazole Market Competition by Manufacturers
2.1 Global Esomeprazole Sales Market Share by Manufacturers (2019-2024)
2.2 Global Esomeprazole Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Esomeprazole Average Price by Manufacturers (2019-2024)
2.4 Global Esomeprazole Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Esomeprazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Esomeprazole, Product Type & Application
2.7 Esomeprazole Market Competitive Situation and Trends
2.7.1 Esomeprazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Esomeprazole Players Market Share by Revenue
2.7.3 Global Esomeprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Esomeprazole Retrospective Market Scenario by Region
3.1 Global Esomeprazole Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Esomeprazole Global Esomeprazole Sales by Region: 2019-2030
3.2.1 Global Esomeprazole Sales by Region: 2019-2024
3.2.2 Global Esomeprazole Sales by Region: 2025-2030
3.3 Global Esomeprazole Global Esomeprazole Revenue by Region: 2019-2030
3.3.1 Global Esomeprazole Revenue by Region: 2019-2024
3.3.2 Global Esomeprazole Revenue by Region: 2025-2030
3.4 North America Esomeprazole Market Facts & Figures by Country
3.4.1 North America Esomeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Esomeprazole Sales by Country (2019-2030)
3.4.3 North America Esomeprazole Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Esomeprazole Market Facts & Figures by Country
3.5.1 Europe Esomeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Esomeprazole Sales by Country (2019-2030)
3.5.3 Europe Esomeprazole Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Esomeprazole Market Facts & Figures by Country
3.6.1 Asia Pacific Esomeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Esomeprazole Sales by Country (2019-2030)
3.6.3 Asia Pacific Esomeprazole Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Esomeprazole Market Facts & Figures by Country
3.7.1 Latin America Esomeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Esomeprazole Sales by Country (2019-2030)
3.7.3 Latin America Esomeprazole Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Esomeprazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Esomeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Esomeprazole Sales by Country (2019-2030)
3.8.3 Middle East and Africa Esomeprazole Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Esomeprazole Sales by Type (2019-2030)
4.1.1 Global Esomeprazole Sales by Type (2019-2024)
4.1.2 Global Esomeprazole Sales by Type (2025-2030)
4.1.3 Global Esomeprazole Sales Market Share by Type (2019-2030)
4.2 Global Esomeprazole Revenue by Type (2019-2030)
4.2.1 Global Esomeprazole Revenue by Type (2019-2024)
4.2.2 Global Esomeprazole Revenue by Type (2025-2030)
4.2.3 Global Esomeprazole Revenue Market Share by Type (2019-2030)
4.3 Global Esomeprazole Price by Type (2019-2030)
5 Segment by Application
5.1 Global Esomeprazole Sales by Application (2019-2030)
5.1.1 Global Esomeprazole Sales by Application (2019-2024)
5.1.2 Global Esomeprazole Sales by Application (2025-2030)
5.1.3 Global Esomeprazole Sales Market Share by Application (2019-2030)
5.2 Global Esomeprazole Revenue by Application (2019-2030)
5.2.1 Global Esomeprazole Revenue by Application (2019-2024)
5.2.2 Global Esomeprazole Revenue by Application (2025-2030)
5.2.3 Global Esomeprazole Revenue Market Share by Application (2019-2030)
5.3 Global Esomeprazole Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca AB
6.1.1 AstraZeneca AB Corporation Information
6.1.2 AstraZeneca AB Description and Business Overview
6.1.3 AstraZeneca AB Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca AB Esomeprazole Product Portfolio
6.1.5 AstraZeneca AB Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Corporation Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sandoz Esomeprazole Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Actavis
6.3.1 Actavis Corporation Information
6.3.2 Actavis Description and Business Overview
6.3.3 Actavis Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Actavis Esomeprazole Product Portfolio
6.3.5 Actavis Recent Developments/Updates
6.4 Teva.
6.4.1 Teva. Corporation Information
6.4.2 Teva. Description and Business Overview
6.4.3 Teva. Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva. Esomeprazole Product Portfolio
6.4.5 Teva. Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Esomeprazole Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 KernPharm
6.6.1 KernPharm Corporation Information
6.6.2 KernPharm Description and Business Overview
6.6.3 KernPharm Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.6.4 KernPharm Esomeprazole Product Portfolio
6.6.5 KernPharm Recent Developments/Updates
6.7 Garmish Pharmaceuticals
6.6.1 Garmish Pharmaceuticals Corporation Information
6.6.2 Garmish Pharmaceuticals Description and Business Overview
6.6.3 Garmish Pharmaceuticals Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Garmish Pharmaceuticals Esomeprazole Product Portfolio
6.7.5 Garmish Pharmaceuticals Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Esomeprazole Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Mepha
6.9.1 Mepha Corporation Information
6.9.2 Mepha Description and Business Overview
6.9.3 Mepha Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mepha Esomeprazole Product Portfolio
6.9.5 Mepha Recent Developments/Updates
6.10 Saval Pharmaceutical
6.10.1 Saval Pharmaceutical Corporation Information
6.10.2 Saval Pharmaceutical Description and Business Overview
6.10.3 Saval Pharmaceutical Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Saval Pharmaceutical Esomeprazole Product Portfolio
6.10.5 Saval Pharmaceutical Recent Developments/Updates
6.11 Stada
6.11.1 Stada Corporation Information
6.11.2 Stada Esomeprazole Description and Business Overview
6.11.3 Stada Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Stada Esomeprazole Product Portfolio
6.11.5 Stada Recent Developments/Updates
6.12 Blaskov
6.12.1 Blaskov Corporation Information
6.12.2 Blaskov Esomeprazole Description and Business Overview
6.12.3 Blaskov Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Blaskov Esomeprazole Product Portfolio
6.12.5 Blaskov Recent Developments/Updates
6.13 CQ Lummy
6.13.1 CQ Lummy Corporation Information
6.13.2 CQ Lummy Esomeprazole Description and Business Overview
6.13.3 CQ Lummy Esomeprazole Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CQ Lummy Esomeprazole Product Portfolio
6.13.5 CQ Lummy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Esomeprazole Industry Chain Analysis
7.2 Esomeprazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Esomeprazole Production Mode & Process
7.4 Esomeprazole Sales and Marketing
7.4.1 Esomeprazole Sales Channels
7.4.2 Esomeprazole Distributors
7.5 Esomeprazole Customers
8 Esomeprazole Market Dynamics
8.1 Esomeprazole Industry Trends
8.2 Esomeprazole Market Drivers
8.3 Esomeprazole Market Challenges
8.4 Esomeprazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
